4-Amido-2-Aryl-1, 2, 4-Triazolo[4, 3-A]quinoxalin-1-Ones as New Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand-Receptor Modeling Studies

doi 10.1021/jm060373w.s001